Company news

INVO Fertility, Inc. news in 2025

INVO Fertility, Inc.'s news releases, calls and decks from 2025, newest first.

View company

INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy

December 30, 2025

INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

December 17, 2025

INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

December 2, 2025

INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

November 28, 2025

INVO Fertility Announces a 1: 8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

November 25, 2025

INVO Fertility Announces Third Quarter 2025 Financial Results

November 17, 2025

INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO’s Wisconsin Fertility Institute

October 27, 2025

INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

September 29, 2025

INVO Fertility Announces Second Quarter 2025 Financial Results

August 14, 2025

INVO Fertility Announces a 1: 3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025

July 17, 2025

INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing

July 9, 2025

INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute

June 30, 2025

INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent

June 25, 2025

INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12: 00 p.m. Eastern Time

June 20, 2025

INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute

June 18, 2025

INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025

June 16, 2025

INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

May 27, 2025

INVO Fertility Announces First Quarter 2025 Financial Results

May 20, 2025

INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA

April 30, 2025

INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”

April 23, 2025

NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”

April 13, 2025

NAYA Announces a 1: 12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025

March 12, 2025

NAYA Biosciences Announces Nomination of New Board Members

February 18, 2025

NAYA Biosciences Announces Pricing of $9.5 Million Public Offering

January 12, 2025

NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody

January 5, 2025

Decks in 2025